Renal cell carcinoma in children and young adults: Analysis of clinicopathological, immunohistochemical and molecular characteristics with an emphasis on the spectrum of Xp11.2 translocation-associated and unusual clear cell subtypes

Histopathology

Volumn 53, Issue 5, 2008, Pages 533-544

  Wu, A ^a   Kunju, L P ^a   Cheng, L ^b   Shah, R B ^a,c  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF MICHIGAN   (United States)

Author keywords

Renal cell carcinoma in children and young adults; TFE3; Xp11.2 translocation associated renal cell carcinoma

Indexed keywords

CYTOKERATIN;

ADOLESCENT; ADULT; ARTICLE; CANCER GRADING; CELL TYPE; CLINICAL ARTICLE; CYTOARCHITECTURE; CYTOPLASM; FEMALE; GENE TRANSLOCATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KIDNEY CARCINOMA; MALE; ONCOCYTOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; SCHOOL CHILD;

ADOLESCENT; CARCINOMA, RENAL CELL; CHILD; CHROMOSOMES, HUMAN, X; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION, FLUORESCENCE; KIDNEY NEOPLASMS; MALE; TRANSLOCATION, GENETIC; YOUNG ADULT;

EID: 54949113945     PISSN: 03090167     EISSN: 13652559     Source Type: Journal    
DOI: 10.1111/j.1365-2559.2008.03151.x     Document Type: Article

References (37)

1. Carcao M, Taylor G, Greenberg M et al. Renal-cell carcinoma in children: a different disorder from its adult counterpart? Med. Pediatr. Oncol. 1998 31 152 158.
2. Bruder E, Passera O, Harms D et al. Morphologic and molecular characterization of renal cell carcinoma in children and young adults. Am. J. Surg. Pathol. 2004 28 1117 1132.
3. Murphy WM, Grignon DJ, Perlman EJ eds. Tumors of the kidney, bladder and related urinary structures. Washington, DC : American Registry of Pathology, 2004.
4. Eble JN, Sauter G, Epstein JI, Sesterhenn IA eds. Pathology and genetics of tumours of the urinary system and male genital organs. Lyon : IARC Press, 2004.
5. Estrada C, Suthar A, Eaton S, Cilento B. Renal cell carcinoma: children's hospital Boston experience. Urology 2005 66 1296 1300.
6. Lack E, Cassady R, Sallan S. Renal cell carcinoma in childhood and adolescence: a clinical and pathological study of 17 cases. J. Urol. 1985 133 822 828.
7. Geller JI, Dome JS. Local lymph node involvement does not predict poor outcome in pediatric renal cell carcinoma. Cancer 2004 101 1575 1583.
8. Geller JI, Argani P, Adeniran A et al. Translocation renal cell carcinoma: lack of negative impact due to lymph node spread. Cancer 2008 112 1607 1616.
9. Argani P, Ladanyi M. Translocation carcinomas of the kidney. Clin. Lab. Med. 2005 25 363 378.
10. Argani P, Antonescu CR, Couturier J et al. PRCC-TFE3 renal carcinomas: morphologic, immunohistochemical, ultrastructural, and molecular analysis of an entity associated with the t(X;1)(p11.2;q21). Am. J. Surg. Pathol. 2002 26 1553 1566.
11. Argani P, Antonescu CR, Illei PB et al. Primary renal neoplasms with the ASPL-TFE3 gene fusion of alveolar soft part sarcoma. Am. J. Pathol. 2001 159 179 192.
12. Argani P, Lal P, Hutchinson B, Lui MY, Reuter V, Ladanyi M. Aberrant nuclear immunoreactivity for TFE3 in neoplasms with TFE3 gene fusions. Am. J. Pathol. 2003 27 750 751.
13. Selle B, Furtwangler R, Graf N, Kaatsch P, Bruder E, Leuschner I. Population-based study of renal cell carcinoma in children in Germany, 1980-2005. Cancer 2006 107 2906 2914.
14. Indolfi P, Terenziani M, Casle F et al. Renal cell carcinoma in children: a clinicopathologic study. J. Clin. Oncol. 2003 21 530 535.
15. Geller JI, Khoury J, Dome J. Local lymph node involvement does not predict poor outcome in pediatric renal cell carcinoma. Author's reply [letter]. Cancer 2005 103 1318.
16. Fuhrman S, Lasky L, Limas C. Prognostic significance of morphologic parameters in renal cell carcinoma. Am. J. Surg. Pathol. 1982 6 655 663.
17. Argani P, Ladanyi M. The evolving story of renal translocation carcinomas. Am. J. Clin. Pathol. 2006 126 332 334.
18. Greene FL, Page DL, Fleming ID et al. eds. AJCC cancer staging manual. New York, NY : Springer, 2002.
19. Oosterwijk E, Bander NH, Divgi C et al. Antibody localization in human renal cell carcinoma: a Phase I study of monoclonal antibody G250. J. Clin. Oncol. 1993 11 738 750.
20. Oosterwijk E, Ruiter D, Hoedemaeker P et al. Monoclonal antibody G250 recognizes a determinant present in renal-cell carcinoma and absent from normal kidney. Int. J. Cancer 1986 38 489 494.
21. Ivanov S, Liao S-Y, Ivanova A et al. Expression of hypoxia-inducible cell-surface transmembrane carbonic anhydrases in human cancer. Am. J. Pathol. 2001 158 905 919.
22. Gobbo S, Eble JN, Grignon DJ et al. Clear cell papillary renal cell carcinoma: a distinct histopathologic and molecular genetic entity. Am. J. Surg. Pathol. 2008 32 1239 1245.
23. Kunju LP, Wojno K, Wolf JS, Cheng L, Shah RB. Papillary renal cell carcinoma with oncocytic cells and nonoverlapping low grade nuclei: expanding the morphologic spectrum with emphasis on clinicopathologic, immunohistochemical, and molecular features. Hum. Pathol. 2008 39 96 101.
24. Argani P, Lui MY, Couturier J, Bouvier R, Fournet J-C, Ladanyi M. A novel CLTC-TFE3 gene fusion in pediatric renal adenocarcinoma with t(X;17)(p11.2;q23). Oncogene 2003 22 5374 5378.
25. Huang F, Zwerdling T, Stern L, Ballard E, Warner B. Renal cell carcinoma as a secondary malignancy after treatment of acute promyelocytic leukemia. J. Pediatr. Hematol./Oncol. 2001 23 609 611.
26. Argani P, Lae M, Ballard E et al. Translocation carcinomas of the kidney after chemotherapy in childhood. J. Clin. Oncol. 2006 24 1529 1534.
27. Ramphal R, Pappo A, Zielenska M, Grant R, Ngan B-Y. Pediatric renal cell carcinoma: clinical, pathologic, and molecular abnormalities associated with the members of the MiT transcription factor family. Am. J. Clin. Pathol. 2006 126 349 364.
28. Rais-Bahrami S, Drabick JJ, De Marzo A et al. Xp11 translocation renal cell carcinoma: delayed but massive and lethal metastases of a chemotherapy-associated secondary malignancy. Urology 2007 70 178.e173 176.
29. Gelb AB, Shibuya RB, Weiss LM, Medeiros LJ. Stage I renal cell carcinoma: a clinicopathologic study of 82 cases. Am. J. Surg. Pathol. 1993 17 275 286.
30. Argani P, Olgac S, Tickoo S et al. Xp11 translocation renal cell carcinoma in adults: expanded clinical, pathologic, and genetic spectrum. Am. J. Surg. Pathol. 2007 31 1149 1160.
31. Meyer PN, Clark JI, Flanigan RC, Picken MM. Xp11.2 translocation renal cell carcinoma with very aggressive course in five adults. Am. J. Clin. Pathol. 2007 128 70 79.
32. Altinok G, Kattar M, Mohamed A, Poulik J, Grignon D, Rabah R. Pediatric renal carcinoma associated with Xp11.2 translocations/TFE3 gene fusions and clinicopathologic associations. Pediatr. Dev. Pathol. 2005 8 168 180.
33. Aronson D, Medary I, Finlay J, Herr H, Exelby P, La Quaglia M. Renal cell carcinoma in childhood and adolescence: retrospective survey for prognostic factors in 22 cases. J. Pediatr. Surg. 1996 31 183 186.
34. Dal Cin P, Stas M, Sciot R, De Wever I, Van Damme B, Van den Berghe H. Translocation (X;1) reveals metastasis 31 years after renal cell carcinoma. Cancer Genet. Cytogenet. 1998 101 58 61.
35. Perot C, Bougaran J, Boccon-Gibod L et al. Two new cases of papillary renal cell carcinoma with t(X;1)(p11;q21) in females. Cancer Genet. Cytogenet. 1999 110 54 56.
36. Garcia JA, Rini BI. Recent progress in the management of advanced renal cell carcinoma. CA Cancer J. Clin. 2007 57 112 125.
37. Tsuda M, Davis IJ, Argani P et al. TFE3 fusions activate MET signaling by transcriptional up-regulation, defining another class of tumors as candidates for therapeutic MET inhibition. Cancer Res. 2007 67 919 929.